Similarly, other researchers have reported that, compared to insulin, metformin treatment better controls postprandial blood sugar during pregnancy reduces the risk of hypoglycemia, and limits maternal weight gain, thereby preventing the onset of GDM in pregnancies with PCOS (Picon-Cesar et al., 2021). Here, INS is linked to polycystic ovary syndrome.